Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Total Liabilities
Everything the company owes to creditors and other parties.
Ambiq Micro, Inc.NYSE: AMBQ
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 16.8% from a year ago
Total liabilities stood at $24.36M at the end of Q1 FY2026, up 16.8% from a year earlier and up 9.6% from the prior quarter.
Context
- Total liabilities amounted to 9.4% of total assets at the end of Q1 FY2026, down 11.6 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +16.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 22.22M USD
- Year-over-year change
- +19.9%
- 5-year CAGR
- +24.7%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 22.22M | +19.9% |
| FY2024 | 2024-12-31 | 18.53M | +39.3% |
| FY2023 | 2023-12-31 | 13.3M | — |
| FY2021 | 2021-12-31 | 16.12M | +118.4% |
| FY2020 | 2020-12-31 | 7.38M | — |
Total Liabilities vs competitors
How AMBQ compares with its peers on the latest reported figures
- AMBQ's Mar 2026 total liabilities of $24.36M is the 9th highest of the 11 companies compared; the peer median is $129.15M.
- Its year-over-year change of +16.8% is the 4th highest of 11, against a peer median of -4.5%.
- Total liabilities amounts to 9.4% of total assets for AMBQ, versus a peer median of 61.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $2.13B | -71.1% | +70.3% | 67.5% | |
| Mar 2026 | $458.41M | -11.2% | -7.5% | 74.3% | |
| Apr 2026 | $382.87M | +3.9% | +2.8% | 194.8% | |
| Sep 2026 | $235.06M | +151.2% | +7.3% | 19.3% | |
| Mar 2026 | $137.29M | +33.1% | +18.5% | 98.1% | |
| Mar 2026 | $121.01M | +1.1% | +0.1% | 59.2% | |
| Mar 2026 | $108.02M | +16.9% | +9.1% | 56.1% | |
| Mar 2026 | $45.31M | -10.2% | -11.0% | 64.0% | |
AMBQAmbiq Micro, Inc. | Mar 2026 | $24.36M | +16.8% | — | 9.4% |
| Mar 2026 | $13.13M | -59.5% | +232.3% | 2.8% | |
NBPNovaBridge Biosciences | Dec 2025 | $4.23M | -95.0% | -84.2% | 11.4% |
| Peer median (excluding AMBQ) | $129.15M | -4.5% | +5.0% | 61.6% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 65.05M | 25.92M | 27.32M | 60.98M | 140.28M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 11M | 20.69M | 12.28M | 10.4M | 7.29M |
| Inventory | 7.44M | 33.68M | 21.48M | 15.01M | 16.94M |
| Other Current Assets | 803K | 2.01M | 2.79M | 2.57M | 2.82M |
| Total Current Assets | 94.79M | 98.84M | 63.86M | 88.96M | 167.32M |
| Property, Plant & Equipment (Net) | 3.2M | 5.49M | 2.97M | 3.54M | 4.78M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.62M | 700K | 5.56M | 11.73M | 11.59M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 81K | 96K | 40K | 49K | 993K |
| Total Non-current Assets | 4.9M | 6.29M | 8.57M | 15.32M | 17.36M |
| Total Assets | 99.68M | 105.13M | 72.43M | 104.28M | 184.68M |
| Account Payables | 2.82M | 11.04M | 2.41M | 2.93M | 8.58M |
| Short-term Debt | 0 | 0 | 0 | 0 | 400K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15K | 34K | 1.55M | 1.7M | 7.4M |
| Total Current Liabilities | 6.08M | 14.8M | 12.92M | 11.77M | 19.18M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.3M | 1.32M | 163K | 6.43M | 2.76M |
| Total Non-current Liabilities | 1.3M | 1.32M | 382K | 6.76M | 3.04M |
| Total Liabilities | 7.38M | 16.12M | 13.3M | 18.53M | 22.22M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (132.76M) | (158.1M) | (277.87M) | (320.25M) | (356.71M) |
| Accumulated OCI | 24K | 200K | (839K) | (520K) | (440K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 92.3M | 89.01M | 59.13M | 85.75M | 162.46M |
| Total Debt | 0 | 0 | 1.02M | 966K | 678K |
| Net Debt | (65.05M) | (25.92M) | (26.3M) | (60.02M) | (139.6M) |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.